SCHEMBL3038085

SCHEMBL3038085

CC(C)(C)OC(=O)n1c(-c2ccc(Cl)c3c2C(=O)NC3)cc2cc(CN3CCC(O)CC3)ccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
POLB P06746 1/20 0.37
BRD4 O60885 1/20 0.36
CREBBP Q92793 1/20 0.36
PARP1 P09874 2/20 0.36
PARP2 Q9UGN5 2/20 0.36
NR1H2 P55055 7/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
DRD4 P21917 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
NR1H3 Q13133 3/20 0.34
PDGFRB P09619 2/20 0.34
KDR P35968 2/20 0.34
PDE2A O00408 1/20 0.33
PDE10A Q9Y233 1/20 0.33
ATR Q13535 1/20 0.33
ATRIP Q8WXE1 1/20 0.33
GPR119 Q8TDV5 1/20 0.33
HSP90AA1 P07900 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3037652 0.94 BRD4 (0.38) KDM4EALDH1A1BRD4CREBBPPARP1
SCHEMBL3044252 0.94 BRD4 (0.36) KDM4EALDH1A1BRD4CREBBPPARP1
SCHEMBL3043652 0.93 HSP90AA1 (0.37) KDM4EALDH1A1BRD4CREBBPPARP1
SCHEMBL3047029 0.92 NR1H2 (0.37) POLBBRD4CREBBPPARP1NR1H2
SCHEMBL3048885 0.92 GPR119 (0.37) KDM4EALDH1A1BRD4CREBBPPARP1
SCHEMBL3047413 0.92 NR1H2 (0.36) POLBBRD4CREBBPNR1H2SMN1; SMN2
SCHEMBL5048276 0.91 PDE2A (0.36) ALDH1A1BRD4CREBBPPARP1PARP2
SCHEMBL3042114 0.91 SMN1; SMN2 (0.39) KDM4EALDH1A1BRD4CREBBPPARP1
SCHEMBL3047734 0.91 VEGFA (0.40) NR1H2GPR119
SCHEMBL3044062 0.91 PARP1 (0.45) PARP1PARP2NR1H2SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745641-B2 Nitrogen-containing heterocyclic compound KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-06-29 US disclosed
US-20090054407-A1 Nitrogen-containing heterocyclic compound KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed
EP-1880993-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND KYOWA HAKKO KOGYO CO., LTD. (JP) 2008-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054407-A1 Nitrogen-containing heterocyclic compound NR4A1, NR5A2, PRMT8 KDM4E 488/4885ALDH1A1 3131/4885POLB 4110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.